

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.384, 2002-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cost effectiveness of tuberculosis treatment programmes
Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. :






Loss Aversion and Cost Effectiveness of Healthcare Programmes
PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. :